These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 12570893)
1. [Research using medication. The regulatory norms must be respected]. Gómez de la Cámara A Aten Primaria; 2003 Jan; 31(1):3-5. PubMed ID: 12570893 [No Abstract] [Full Text] [Related]
2. Neonatal drug trials: impact of EU and US paediatric regulations. Pansieri C; Bonati M; Choonara I; Jacqz-Aigrain E Arch Dis Child Fetal Neonatal Ed; 2014 Sep; 99(5):F438. PubMed ID: 24792777 [No Abstract] [Full Text] [Related]
3. New European regulation for clinical trials of medicinal products. Lemaire F; Matei M; Juvin P Am J Respir Crit Care Med; 2015 Jan; 191(1):16-8. PubMed ID: 25551347 [No Abstract] [Full Text] [Related]
4. A critique of emerging European legislation in the pharmaceutical industry: a clinical trials analysis. Murray E; McAdam R; Burke MT Int J Health Care Qual Assur Inc Leadersh Health Serv; 2004; 17(7):389-93. PubMed ID: 15552394 [TBL] [Abstract][Full Text] [Related]
6. [Ethics Review Boards discriminate the most severely ill--Swedish researchers are prevented to participate in an international study]. Björck M; Berg B; Hedin U; Wingren U Lakartidningen; 2010 May 26-Jun 1; 107(21):1356-7. PubMed ID: 20645608 [No Abstract] [Full Text] [Related]
7. Japanese abandon domestic trials. Saegusa A Nat Biotechnol; 1998 Oct; 16(10):898-9. PubMed ID: 9788333 [No Abstract] [Full Text] [Related]
8. EU law mandates drug testing in children. Sinha G J Natl Cancer Inst; 2008 Jan; 100(2):84-5. PubMed ID: 18182609 [No Abstract] [Full Text] [Related]
11. Clinical drug evaluation: the regulatory perspectives. Ng TL Ann Acad Med Singap; 2000 Sep; 29(5):616-20. PubMed ID: 11126697 [TBL] [Abstract][Full Text] [Related]
12. Throwing a wrench in the works? Meunier F; Dubois N; Negrouk A; Rea LA; Saghatchian M; Tursz T; Sullivan R; Law K; Tiner R Lancet Oncol; 2003 Dec; 4(12):717-9. PubMed ID: 14662426 [No Abstract] [Full Text] [Related]
13. Federal legislation and the advancement of neonatal drug studies. Wiles JR; Vinks AA; Akinbi H J Pediatr; 2013 Jan; 162(1):12-5. PubMed ID: 23110945 [No Abstract] [Full Text] [Related]
14. International regulatory aspects of clinical periodontal research. Cooley WE; Castellion AW Ann Periodontol; 1997 Mar; 2(1):18-30. PubMed ID: 9151540 [TBL] [Abstract][Full Text] [Related]
15. Regulations and procedures for new drug evaluation and approval in China. Yin H Hum Gene Ther; 2006 Oct; 17(10):970-4. PubMed ID: 16958562 [No Abstract] [Full Text] [Related]
16. Is it time to discuss on low-intervention clinical trials without participants' informed consent? Dal-Ré R; Carné X Med Clin (Barc); 2018 May; 150(9):345-347. PubMed ID: 29196035 [No Abstract] [Full Text] [Related]
17. Preliminary appraisal of clinical drug trials is changing. Konttinen O; Närhi U Duodecim; 2017; 133(6):607-13. PubMed ID: 29243893 [TBL] [Abstract][Full Text] [Related]
18. The pharmaceutical industry and oncology in central and eastern Europe. Ben-Am M; Gemperli B; Covelli A; Burke G Ann Oncol; 1999; 10 Suppl 6():15-7. PubMed ID: 10676548 [TBL] [Abstract][Full Text] [Related]
19. The FDA Amendments Act of 2007 - Assessing Its Effects a Decade Later. Avorn J; Kesselheim A; Sarpatwari A N Engl J Med; 2018 Sep; 379(12):1097-1099. PubMed ID: 30231220 [No Abstract] [Full Text] [Related]
20. Drug evaluation and approval in the European Community. Marty M Eur J Cancer; 1996 Apr; 32A(4):574-5. PubMed ID: 8695255 [No Abstract] [Full Text] [Related] [Next] [New Search]